• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    ARCA biopharma, Inc. (ABIO)

    -NasdaqCM
    0.92 Down 0.01(1.06%) Dec 26, 3:57PM EST
    Add to Portfolio
    Prev Close:0.93
    Open:0.93
    Bid:N/A
    Ask:1.10 x 1000
    1y Target Est:3.75
    Beta:3.35
    Next Earnings Date:N/A
    Day's Range:0.90 - 0.94
    52wk Range:0.70 - 2.54
    Volume:88,389
    Avg Vol (3m):394,998
    Market Cap:19.46M
    P/E (ttm):N/A
    EPS (ttm):-0.52
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ABIO

    Comparison

    Symbol% ChgMkt Cap
    ABIODown 1.06%19.46M
    AZNUp 0.67%89.56B
    GSKUp 0.70%103.73B
    ILIUUp 9.29%14.71M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatm... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback